Vitamin E: Where Are We Now in Vascular Diseases?

被引:12
|
作者
Garg, Anahita [1 ]
Lee, Jetty Chung-Yung [1 ]
机构
[1] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China
来源
LIFE-BASEL | 2022年 / 12卷 / 02期
关键词
vitamin E; tocopherol; antioxidant; oxidation; cardiovascular diseases; atherosclerosis; low-density lipoprotein; ALPHA-TOCOPHERYL PHOSPHATE; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; E SUPPLEMENTATION; CORONARY-DISEASE; INDUCED ADHESION; GENE-EXPRESSION; WOMENS-HEALTH; E CONSUMPTION;
D O I
10.3390/life12020310
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vitamin E is one of the most popular fat-soluble vitamins in pathological research and has been under scrutiny since the 1980s as a vital dietary component of food. The antioxidant effect of vitamin E has been widely studied due to its benefits in the prevention of various cardiovascular diseases. In recent years, alternative effects of vitamin E, in terms of anti-inflammatory pathways and gene regulation, have also been of interest to researchers. This review examines the role of dietary vitamin E (alpha-tocopherol) as an antioxidant and bioactive molecule in promoting vascular health. While the antioxidant effect of vitamin E is well established, knowledge about its capacity as a promising regulatory molecule in the control of the vascular system is limited. The aim of this review is to discuss some of these mechanisms and summarize their role in the prevention of cardiovascular diseases (CVD). Here, we also briefly discuss foods rich in vitamin E, and deliberate some potential toxicological effects of excessive supplemental vitamin E in the body.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Where Are we with Vitamin E?
    David A. Morrow
    [J]. Journal of Thrombosis and Thrombolysis, 1998, 5 : 209 - 214
  • [2] Where are we with vitamin E?
    Morrow, DA
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1998, 5 (03) : 209 - 214
  • [3] Vitamin A for preterm infants; where are we now?
    Mactier, Helen
    [J]. SEMINARS IN FETAL & NEONATAL MEDICINE, 2013, 18 (03): : 166 - 171
  • [4] Vitamin D and fractures: Where are we now?
    Aspray, T. J.
    Francis, R. M.
    [J]. MATURITAS, 2010, 66 (03) : 221 - 222
  • [5] Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go?
    Screm, Gianluca
    Mondini, Lucrezia
    Salton, Francesco
    Confalonieri, Paola
    Trotta, Liliana
    Barbieri, Mariangela
    Romallo, Antonio
    Galantino, Alessandra
    Hughes, Michael
    Lerda, Selene
    Confalonieri, Marco
    Ruaro, Barbara
    [J]. DIAGNOSTICS, 2024, 14 (09)
  • [6] Vascular factors in cognitive impairment - Where are we now?
    Hachinski, V
    Munoz, D
    [J]. VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 : 1 - 5
  • [7] Perceived Stress and Vascular Disease: Where Are We Now?
    Katsarou, Alexia L.
    Triposkiadis, Filippos
    Panagiotakos, Demosthenes
    [J]. ANGIOLOGY, 2013, 64 (07) : 529 - 534
  • [8] Where Are We Now With Bilirubin as a Marker of Vascular Risk?
    Breimer, Lars H.
    [J]. ANGIOLOGY, 2014, 65 (03) : 177 - 179
  • [9] Cardiac MRI in Autoimmune Diseases: Where Are We Now?
    Vallianou, Natalia G.
    Geladari, Eleni
    Panagopoulos, Fotis
    Kalantzi, Maria
    [J]. CURRENT CARDIOLOGY REVIEWS, 2021, 17 (05)
  • [10] SKELETAL PALEOPATHOLOGY AND THE RHEUMATIC DISEASES - WHERE ARE WE NOW
    ROGERS, J
    DIEPPE, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (11) : 885 - 886